A Look At American Healthcare REIT (AHR) Valuation After RBC’s Higher 2026 FFO Estimate

RBC Capital Markets’ decision to lift its 2026 funds from operations estimate for American Healthcare REIT (AHR) to US$2.04 per share, tied to a higher investment pace, has put fresh attention on the stock.

See our latest analysis for American Healthcare REIT.

The latest analyst revision comes as American Healthcare REIT trades at US$50.58, with a 1-day share price return of 2.22% and a 7-day share price return of 2.99%. The 1-year total shareholder return of 69.18% points to strong momentum building over a longer horizon, despite a 4.62% 1-month share price pullback.

If you are looking beyond AHR for ideas in the broader healthcare space, this could be a good moment to scan for other healthcare-focused opportunities using our 35 healthcare AI stocks.

With American Healthcare REIT trading at a discount of about 14% to the latest analyst price target and an indicated 42% gap to one intrinsic value estimate, you have to ask: is there still upside here, or is the market already pricing in future growth?

Most Popular Narrative: 12.9% Undervalued

At $50.58, the most followed narrative sees fair value for American Healthcare REIT closer to $58.08, built on detailed long term growth and margin assumptions.

The combination of a rapidly growing 80+ demographic and a multi-year period of low new supply in senior housing and skilled nursing is expected to drive a persistent supply-demand imbalance, fueling both occupancy gains and rent growth across American Healthcare REIT's portfolio, this dynamic should underpin above-trend revenue and net operating income growth over the next decade.

Read the complete narrative.

Want to see what sits behind that growth story? The narrative leans on faster revenue expansion, rising margins, and a higher future earnings multiple than peers.

Result: Fair Value of $58.08 (UNDERVALUED)

Have a read of the narrative in full and understand what's behind the forecasts.

However, you also have to weigh that growth story against risks such as occupancy flattening in key segments and pressure on margins if reimbursement terms become less favorable.

Find out about the key risks to this American Healthcare REIT narrative.

Another Take: Earnings Multiple Paints A Richer Picture

The fair value narrative and DCF view suggest upside, but the current P/E of 139x is far above the estimated fair ratio of 44.1x, the US Health Care REITs industry at 40.6x, and the peer average of 63.7x. That gap points to meaningful valuation risk if sentiment cools.

For a closer look at how this price stacks up against earnings and peers in practice, check the detailed breakdown in our See what the numbers say about this price — find out in our valuation breakdown.

Next Steps

Mixed signals in the story so far? Given the combination of concerns and reasons for optimism, it makes sense to review the data yourself and then weigh up the 3 key rewards and 3 important warning signs

Looking for more investment ideas?

Do not stop with a single stock view. Broaden your options with focused screeners that surface clear, data driven ideas tailored to different investing goals.

• Target potential upside with a curated list of companies that combine quality and value using the 58 high quality undervalued stocks.
• Prioritise resilience by filtering for companies with robust finances and dependable fundamentals through the solid balance sheet and fundamentals stocks screener (42 results).
• Spot opportunities that many investors may be overlooking by scanning the screener containing 23 high quality undiscovered gems.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com